The value of radiosurgery in the first line therapy of glioblastoma multiforme. The Heidelberg experience and review of the literature;Stellenwert der radiochirurgie in der primartherapie des glioblastoma multiforme: Heidelberger erfahrungen im literaturvergleich

Strahlentherapie und Onkologie

Volumn 174, Issue 4, 1998, Pages 187-192

  Van Kampen, M ^a   Engenhart Cabillic, R ^a   Debus, J ^a   Fuss M ^a   Rhein, B ^b   Wannenmacher, M ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Glioblastoma multiforme; Radiosurgery

Indexed keywords

ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; GERMANY; GLIOBLASTOMA; HUMAN; MINIMAL RESIDUAL DISEASE; QUALITY OF LIFE; RADIATION DOSE; RADIOSURGERY;

EID: 0031944392     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03038525     Document Type: Article

References (43)

1. Albert FK, Forsting M, Sartor K, Adams HP, Kuze S. Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery 1994;34:45-61.
2. Bock J, Bamberg M, Krauseneck P, Müller B. Multi-Center-Studie der Neuroonkologischen Arbeitsgemeinschaft in der Deutschen Krebsgesellschaft: Risikoadaptierte multimodale Therapie maligner Gliome als Phase-III-Studie (NOA-01). Studienprotokoll, Würzburg, 1993.
3. Buatti JM, Marcus RB, Mendenhall WM, Friedmann WA, Bova FJ. Accelerated hyperfractionated radiotherapy for malignant gliomas. Int J Radiat Oncol Biol Phys 1996;34:785-92.
4. Curran WJ, Scott CB, Horton J et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. JNCI 1993;85:704-10.
5. Engenhart R, Kimmig BN, Höver KH et al. Long-term follow-up for brain metastases treated by percutaneous stereotactic single high-dose irradiation. Cancer 1993;71:1353-61.
6. Fernandez PM, Zamorano L, Yakar D, Gaspar L, Warmelink C. Permanent iodine-125 implants in the up-front treatment of malignant gliomas. Neurosurgery 1995;36:467-73.
7. Fine HA, Dear KGB, Loeffler JS, Black P McL, Canellos GP. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 1993;71:2585-97.
8. Forsting M, Albert FK, Sartor K, Kunze S. Early postoperative CT and MRI in glioblastoma. Neuroradiology 1991;33:Suppl:25-7.
9. Fujiwara T, Honma Y, Ogawa T et al. Intraoperative radiotherapie for gliomas. J Neurol Oncol 1995;23:81-6.
10. Gannett D, Stea B, Lulu B, Adair T, Verdi C, Hamilton A. Stereotactic radiosurgery as an adjunct to surgery and external beam radiotherapy in the treatment of patients with malignant gliomas. Int J Radiat Oncol Biol Phys 1995;33:461-8.
11. Gonzalez-Gonzalez D, Menten J, Bosch DA et al. Accelerated radiotherapy in glioblastoma multiforme: a dose searching prospective study. Radiother Oncol 1994;32:98-105.
12. Hartmann GH, Schlegel W, Sturm V, Kober B, Pastyr O, Lorenz WJ. Cerebral radiation surgery using moving field irradiation at a linear accelerator facility. Int J Radiat Oncol Biol Phys 1985;1:1185-92.
13. Hochberg FH, Pruit A. Assumptions in theradiotherapy of glioblastoma. Neurology 1980;30:907-11.
14. ICRU Report 50. Prescribing, recording and reporting photon beam therapy. International Commission on Radiation Units and Measurements. Bethesda, MD, 1993.
15. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
16. Kelly PJ, Daumas-Duport C, Kispert DB, Kall BA, Scheithauer BW, Illig JJ. Imaging-basad stereotaxic serial biopsies in untreated intracranial glial neoplasms. J Neurosurg 1987;66:865-74.
17. Kelly PJ, Hunt C. The limited value of cytoreductive surgery in elderly patients with malignant gliomas. Neurosurgery 1994;34:62-7.
18. Kernohan JW, Mabon RF, Svien HJ, Adson AW. A simplified classification of gliomas. Proc Staff Meet Mayo Clin 1949;24:71-5.
19. Kjellberg RN, Hanamura T, Davis KR. Bragg-peak proton-beam therapy for arteriovenous malformations of the brain. N Engl J Med 1983;309: 269-82.
20. Kreth FW, Warnke PC, Scherement R, Ostertag CB. Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme. J Neurosurg 1993;78:762-6.
21. Kristiansen K, Hagen S, Kollevold T et al. Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study Group. Cancer 1981;47:649-52.
22. Leksell L. The stereotaxic method and radiosurgery of the brain. Acta Chir Scand 1951;102:316-20.
23. Loeffler JS, Alexnder E III, Hochberg FH et al. Clinical patterns of failure following stereotactic interstitial irradiation for malignant gliomas. Int J Radiat Oncol Biol Phys 1990;19:1455-62.
24. Loeffler JS, Alexnder E III, Shea WM et al. Radiosurgery as part of the initial management of patients with malignant gliomas. J Clin Oncol 1992;10:1379-85.
25. Masciopinto JE, Levin AB, Mehta MP, Rhode BS. Stereotactic radiosurgery for glioblastoma: a final report of 31 patients. J Neurosurg 1995;82: 530-5.
26. Matsutani M, Nakamura O, Nagashima T et al. Intra-operative radiation therapy for malignant brain tumours: rationale, method, and treatment results of cerebral glioblastomas. Acta Neurochir (Wien) 1994;131:80-90.
27. Mundinger F, Weigel K. Long-term results of stereotactic interstitial curietherapie. Acta Neurochir 1984;Suppl 33:367-71.
28. Nelson DF, Diener-West M, Horton J, Nelson JS, Chang CH, Schoenfeld D. Combined modality approach to treatment of malignant gliomas - reevaluation of RTOG 74-01/ECOG 13-74 with long-term follow-up: a joint study of the Radiation Therapy Oncology Group and the Eastern Cooperative Oncology Group. NCI Monogr 1988;6:279-84.
29. Ostertag CB, Kreth FW. Iodine-125 interstitial irradiation for cerebral gliomas. Acta Neurochir 1992;119:53-61.
30. Rhein B, Engenhart R, Debus J et al. Stereotaktische Hochdosis-Konvergenztherapie bei irregulär geformten Zielvolumina. Beschreibung einer Mehrfeldertechnik mit 11 bis 14 nicht koplanaren irregulären Stehfeldern. In: Tautz M, Hrsg. Med Phys 1994;94:224-5.
31. Rhein B, Höver KH, Lorenz WJ. Dosimetrische Verifikation bei non koplanaren isozentrischen Mehrfeld-Bestrahlungen mit irregulärer Feldanpassung im Kopf-Hals-Bereich. In: Jordan K, Hrsg. Med Phys 1991; 91:54-5.
32. Sarkaria JN, Mehta MP, Loeffler JS et al. Radiosurgery in the initial management of malignant gliomas: survival comparison with the RTOG recursive partitioning analysis. Int J Radiat Oncol Biol Phys 1995;32:931-41.
33. Sauter-Bihl M-L, Barcsay E, Liebermeister E, Winheller R, Liesegang J, Heinze HG. Strahlentherapie des Glioblastoms: Ist eine Verkürzung der Behandlungszeit vertretbar? Strahlenther Onkol 1991;167:7-13.
34. Schlegel W, Scharfenberg H, Doll J, Hartmann G, Sturm V, Lorenz WJ. Threedimensional dose planning using tomographic data. Proc. 8th Int. Conference on the Use of Computers in Radiation Therapy. Silver Spring: IEEE Computer Society Press, 1984:191-5.
35. Sneed PK, Gutin PH, Larson DA et al. Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost. Int J Radiat Oncol Biol Phys 1994;29:719-27.
36. Sneed PK, Lamborn KR, Larson DA et al. Demonstration of brachytherapy boost dose-response relationship in glioblastoma multiforme. Int J Radiat Oncol Biol Phys 1996;35:37-44.
37. Sparrenberg A, Ernst H. Der Stellenwert der fraktionierten Afterloading-Therapie in der Behandlung inoperabler maligner Hirntumoren. Strahlenther Onkol 1990;166:251-5.
38. Stea B, Rossmann K, Kittelson J, Shetter A, Hamilton A, Cassady JR. Interstitial irradiation versus interstitial thermoradiotherapy for supratentorial malignant gliomas: a comparative survival analysis. Int J Radiat Oncol Biol Phys 1994;30:591-600.
39. Sturm VB, Kober K, Höver H et al. Stereotactic percutaneous single dose irradiation of brain metastases with a linear accelerator. Int J Radiat Oncol Biol Phys 1987;13:279-82.
40. Wagner W, Schüller P, Willich N et al. Intraoperative Strahlentherapie (IORT) maligner Hirntumoren. Strahlenther Onkol 1995;171:154-64.
41. Walker MD, Strike TA, Sheline GE. An analysis of dose-effect relationship in radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 1979;5:1725-31.
42. Werner-Wasik M, Scott CB, Nelson DF et al. Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas. Cancer 1996;77:1535-43.
43. Zülch KJ. Principles of the new World Health Organisation (WHO) classification of brain tumors. Neuroradiology 1980;19:59-66.